Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyalgan for Knee Osteoarthritis Pain (TREAD-20)
NCT00130468Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of sodium hyaluronate in osteoarthritis (OA), sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00130468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130468.